臨床研究等提出・公開システム

Fecal microbiota transplantation for intractable gastrointestinal diseases
(FEMIGI study)

Fecal microbiota transplantation for intractable gastrointestinal diseases
(FEMIGI study)

Ohmiya Naoki

Fujita Health University Hospital

1-98 Dengakugakubo Kutsukake-cho Toyoake Aichi

nohmiya@fujita-hu.ac.jp

Ohmiya Naoki

Fujita Health University Hospital

1-98 Dengakugakubo Kutsukake-cho Toyoake Aichi

+81-562-93-9240

nohmiya@fujita-hu.ac.jp

Recruiting

April. 23, 2019

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

(1)recipient
A patient who provides the informed consent or legally acceptable representatives of whom provide the informed consent
(2)donor
with all negative screening tests

(1)recipient
1) past history of allergy to drugs used in this study
2) possible of documented pregnant women
3) judged to be inappropriate by the investigator
(2)donor
1) person who is not compatible to the selection criteria
2) person with past history of allergy to drugs used in this study
3) possible of documented pregnant women
4) person with suspected or documented bowel obstruction
5) person with gastrointestinal tumors
6) person who was judged to be inappropriate

Both

1)Clostridium difficile infection 2)Crohn disease, ulcerative colitis 3)Chronic Enteropathy associat

fecal microbiota transplatation

Safety in FMT

The effectiveness and acceptance of FMT

+81-562-93-2865

April. 08, 2019

none